A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer

BACKGROUND: Infusional fluorouracil/leucovorin (FU/LV) plus irinotecan (FOLFIRI) is one of the standard first-line options for patients with metastatic colorectal cancer (mCRC). Irinotecan is converted into 7-ethyl-10-hydroxycamptothecin (SN-38) by a carboxylsterase and metabolised through uridine d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Marcuello, E, Páez, D, Paré, L, Salazar, J, Sebio, A, del Rio, E, Baiget, M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2011
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3137420/
https://ncbi.nlm.nih.gov/pubmed/21654688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.206
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi